- Home
- STRO vs ACCD Comparison
STRO vs ACCD Comparison
Compare STRO & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- ACCD
- Stock Information
- Founded
- STRO 2003
- ACCD 2007
- Country
- STRO United States
- ACCD United States
- Employees
- STRO N/A
- ACCD N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- ACCD Business Services
- Sector
- STRO Health Care
- ACCD Consumer Discretionary
- Exchange
- STRO Nasdaq
- ACCD Nasdaq
- Market Cap
- STRO 172.8M
- ACCD 281.1M
- IPO Year
- STRO 2018
- ACCD 2020
- Fundamental
- Price
- STRO $1.94
- ACCD $3.53
- Analyst Decision
- STRO Strong Buy
- ACCD Buy
- Analyst Count
- STRO 7
- ACCD 12
- Target Price
- STRO $12.14
- ACCD $8.96
- AVG Volume (30 Days)
- STRO 1.4M
- ACCD 1.0M
- Earning Date
- STRO 11-13-2024
- ACCD 01-09-2025
- Dividend Yield
- STRO N/A
- ACCD N/A
- EPS Growth
- STRO N/A
- ACCD N/A
- EPS
- STRO N/A
- ACCD N/A
- Revenue
- STRO $160,955,000.00
- ACCD $441,028,000.00
- Revenue This Year
- STRO N/A
- ACCD $14.58
- Revenue Next Year
- STRO N/A
- ACCD $12.65
- P/E Ratio
- STRO N/A
- ACCD N/A
- Revenue Growth
- STRO 230.90
- ACCD 16.04
- 52 Week Low
- STRO $1.70
- ACCD $3.08
- 52 Week High
- STRO $6.13
- ACCD $15.36
- Technical
- Relative Strength Index (RSI)
- STRO 28.52
- ACCD 43.33
- Support Level
- STRO $1.70
- ACCD $3.41
- Resistance Level
- STRO $1.93
- ACCD $3.61
- Average True Range (ATR)
- STRO 0.20
- ACCD 0.16
- MACD
- STRO -0.01
- ACCD -0.02
- Stochastic Oscillator
- STRO 12.60
- ACCD 35.10
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About ACCD Accolade Inc.
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.